2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl 2-(2H3)methyl(2H4)propanoate

• ChemBase编号: 164744
• 分子式: C32H44O7
• 平均质量: 540.68756
• 单一同位素质量: 540.30870375
• SMILES: C1=C[C@]2(C(=CC1=O)CC[C@@H]1[C@@H]2[C@H](C[C@]2([C@H]1C[C@@H]1[C@]2(O[C@@H](O1)C1CCCCC1)C(=O)COC(=O)C(C)C)C)O)C
• Canonical SMILES: O=C(C(C)C)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1CCC1=CC(=O)C=C[C@]21C)C1CCCCC1
• InChI: InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1
• InChIKey: LUKZNWIVRBCLON-GXOBDPJESA-N

名称和登记号

名称

• IUPAC标准名: 2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^2,^9.0^4,^8.0^1^3,^1^8]icosa-14,17-dien-8-yl]-2-oxoethyl 2-(^2H₃)methyl(^2H₄)propanoate
• IUPAC传统名: 2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^2,^9.0^4,^8.0^1^3,^1^8]icosa-14,17-dien-8-yl]-2-oxoethyl 2-(^2H₃)methyl(^2H₄)propanoate
• 别名: (11β,16α)-16,17-[[(R)-Cyclohexyl-methylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy-d7)-pregna-1,4-diene-3,20-dione; Alvesco-d7; Omnaris-d7; RPR 251526-d7; Ciclesonide-d7

登记号

• CAS号: 1225382-70-6
• PubChem SID: 162258879
• PubChem CID: 46218753

理论计算性质

• Acid pKa: 14.7785225
• 质子受体: 6
• 质子供体: 1
• LogD (pH = 5.5): 5.3232727
• LogD (pH = 7.4): 5.3232727
• Log P: 5.3232727
• 摩尔折射率: 146.2789 cm^3
• 极化性: 57.75212 Å^3
• 极化表面积: 99.13 Å^2
• 可自由旋转的化学键: 6
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Chloroform; Methanol
• 外观: White to Off-White Solid
• 熔点: 116-118°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - C432693

A labelled glucocorticoid microemulsion nasal preparation allergy inhibitor rhinitis.

参考文献

• ukuoka, E., et al.: Chem. Pharm. Bull., 35, 2943 (1987)
• Schmitt, E., et al.: J. Pharm. Sci., 88, 291 (1987)
• Hancock, B., et al.: Pharm. Res., 17, 397 (1987)
• Hogan, S., et al.: Pharm. Res., 18, 112 (2001).